Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.68 |
| ▸ | TSPO | P30536 | 4/20 | 0.61 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | FABP4 | P15090 | 3/20 | 0.53 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.53 |
| ▸ | FABP3 | P05413 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.49 |
| ▸ | BACE1 | P56817 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1128309 | 0.84 | KDM4E (0.63) | KDM4ETSPOGLAPOLBMAPT | |
| SCHEMBL14448728 | 0.83 | ALDH1A1 (0.62) | KDM4ETSPOGLAPOLBHDAC6 | |
| SCHEMBL14003751 | 0.83 | KDM4E (0.73) | KDM4ETSPOGLAPOLBFABP4 | |
| SCHEMBL14003754 | 0.83 | KDM4E (0.73) | KDM4ETSPOGLAPOLBFABP4 | |
| SCHEMBL28165495 | 0.83 | KDM4E (0.61) | KDM4ETSPOGLAPOLBFABP4 | |
| SCHEMBL13332552 | 0.82 | MAPT (0.61) | KDM4EPOLBMAPTALDH1A1 | |
| SCHEMBL31567562 | 0.81 | KDM4E (0.59) | KDM4ETSPOGLAPOLBFABP4 | |
| SCHEMBL28007692 | 0.81 | KDM4E (0.59) | KDM4ETSPOGLAPOLBFABP4 | |
| SCHEMBL27151558 | 0.81 | KDM4E (0.59) | KDM4ETSPOGLAPOLBFABP4 | |
| SCHEMBL150053 | 0.81 | KDM4E (1.00) | KDM4ETSPOGLAPOLBFABP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019033171-A1 | CELL CULTURE SUBSTRATES | MACQUARIE UNIVERSITY (AU) | 2019-02-21 | — | — | WO | disclosed |
| US-10005730-B2 | 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2018-06-26 | — | — | US | disclosed |
| CN-105517990-A | Oligomeric aminoketones and their use as photoinitiators | SUN CHEMICAL CORP | 2016-04-20 | — | — | CN | disclosed |
| US-20160102056-A1 | 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2016-04-14 | — | — | US | disclosed |
| US-9249097-B2 | 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2016-02-02 | — | — | US | disclosed |
| US-20140107174-A1 | 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR | AZIENDE CHIM. RIUN. ANG. FRANC. AC.R.A.F. S.p.A. (IT) | 2014-04-17 | — | — | US | disclosed |
| US-8637682-B2 | 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2014-01-28 | — | — | US | disclosed |
| CN-102026973-B | 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor | ACRAF | 2013-07-10 | — | — | CN | disclosed |
| EP-2282994-B1 | 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR | ACRAF (IT) | 2013-07-03 | — | — | EP | disclosed |
| CN-102026973-A | 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor | ACRAF | 2011-04-20 | — | — | CN | disclosed |
| US-20110060025-A1 | 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR | AZIENDE CHIM. RIUN.ANG.FRANC. A.C.R.A.F S.p.A. (IT) | 2011-03-10 | — | — | US | disclosed |
| EP-2282994-A1 | 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. (IT) | 2011-02-16 | — | — | EP | disclosed |
| WO-2009138376-A1 | 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2009-11-19 | — | — | WO | disclosed |
| EP-2119705-A1 | 3-Aminocarbozole compound, pharmaceutical composition containing it and preparation method therefor | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (IT) | 2009-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10005730-B2 | 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor | PTGES3, PTGER3, PTGES | KDM4E 3682/4885TSPO 135/4885GLA 2312/4885 |
| US-20160102056-A1 | 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR | PTGES3, PTGER3, PTGES | KDM4E 3682/4885TSPO 135/4885GLA 2312/4885 |
| US-20140107174-A1 | 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR | PTGES3, PTGER3, PTGES | KDM4E 3682/4885TSPO 135/4885GLA 2312/4885 |
| US-20110060025-A1 | 3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR | PTGES3, PTGER3, PTGES | KDM4E 3682/4885TSPO 135/4885GLA 2312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.